Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
Valentina Guarnotta, Maria J. Bianco, Enrica Vigneri, Felicia Panto’, Bruna Lo Sasso, Marcello Ciaccio, Giuseppe Pizzolanti, Carla Giordano
Topics & Concepts
Internal medicineEndocrinologyMedicineMyokineLiraglutideDiabetes mellitusType 2 Diabetes MellitusType 2 diabetesInsulinCholesterolInsulin resistanceSkeletal muscleAdipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated Receptors